Cargando…

Soluble osteopontin concentrations in serum and ascites of women with advanced serous ovarian cancer

Detalles Bibliográficos
Autores principales:	Černe, Katarina, Bačnik, Ana, Galič-Jerman, Katarina, Kobal, Borut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506339/ http://dx.doi.org/10.1186/2050-6511-13-S1-A72

Ejemplares similares

Circulating serum sVCAM-1 concentration in advanced ovarian cancer patients: correlation with concentration in ascites
por: Jakimovska, Marina, et al.
Publicado: (2014)

Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy
por: Jerman, Katarina Galic, et al.
Publicado: (2014)

Potential of Osteopontin in the Management of Epithelial Ovarian Cancer
por: Cerne, Katarina, et al.
Publicado: (2019)

High preoperative serum sVCAM-1 concentration as a predictor of early ovarian cancer recurrence
por: Jakimovska, Marina, et al.
Publicado: (2020)

Application of Dynamic and Static Light Scattering for Size and Shape Characterization of Small Extracellular Nanoparticles in Plasma and Ascites of Ovarian Cancer Patients
por: Kogej, Ksenija, et al.
Publicado: (2021)

Characteristics of Extracellular Vesicles from a High-Grade Serous Ovarian Cancer Cell Line Derived from a Platinum-Resistant Patient as a Potential Tool for Aiding the Prediction of Responses to Chemotherapy
por: Černe, Katarina, et al.
Publicado: (2023)

Expression of organic cation transporter 3 (SLC22A3) and plasma membrane monoamine transporter (SLC29A4) in human umbilical vein endothelial cells and their relevance for histamine uptake
por: Ferk, Polonca, et al.
Publicado: (2012)

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
por: Zhang, Jie, et al.
Publicado: (2022)

Benign serous ovarian tumour: a redefining moment?
por: Hunter, Sally, et al.
Publicado: (2012)

Serum concentrations of soluble (s)L- and (s)P-selectins in women with ovarian cancer
por: Majchrzak-Baczmańska, Dominika B., et al.
Publicado: (2018)

The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
por: Škof, Erik, et al.
Publicado: (2016)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Osteopontin Serum Concentration and Metabolic Syndrome in Male Psoriatic Patients
por: Bartosińska, Joanna, et al.
Publicado: (2021)

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
por: Chen, Wenying, et al.
Publicado: (2023)

Toxicological Properties of Δ(9)-tetrahydrocannabinol and Cannabidiol
por: Černe, Katarina
Publicado: (2020)

Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
por: Weiland, Florian, et al.
Publicado: (2012)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients
por: Gericke, Beate, et al.
Publicado: (2005)

Serum concentration of selected macro- and microelements and their correlation with the risk of breast and ovarian cancer among BRCA1 mutation carriers
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Molecular Profiling and Clinical Outcome of High-Grade Serous Ovarian Cancer Presenting with Low- versus High-Volume Ascites
por: Feigenberg, Tomer, et al.
Publicado: (2014)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

Virome Analysis of Signal Crayfish (Pacifastacus leniusculus) along Its Invasion Range Reveals Diverse and Divergent RNA Viruses
por: Bačnik, Katarina, et al.
Publicado: (2021)

Osteopontin as a Tumor Marker in Ovarian Cancer
por: Rani, Shikha, et al.
Publicado: (2022)

Plasma osteopontin concentrations in patients with cutaneous melanoma
por: FILIA, A., et al.
Publicado: (2013)

Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid
por: Sharma, Sudha, et al.
Publicado: (2021)

Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023)

Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum
por: Tarn, JR, et al.
Publicado: (2013)

Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer
por: Aquino-Acevedo, Alexandra N., et al.
Publicado: (2022)

Factors influencing serum lactate concentration in ICU newborns
por: Maruniak-Chudek, I, et al.
Publicado: (1998)

The psychological concept of social sustainability in the workplace from the perspective of sustainable goals: A systematic review
por: Kobal Grum, Darja, et al.
Publicado: (2022)

Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and activity of semicarbazide-sensitive amine oxidase
por: Koborová, Ivana, et al.
Publicado: (2017)

Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment
por: Dong, Ying, et al.
Publicado: (2013)

Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIc to IV high-grade serous ovarian cancer
por: Xu, Xia, et al.
Publicado: (2016)

DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer
por: Zhu, Fang, et al.
Publicado: (2022)

Clinical significance of CD8‐positive lymphocytes on tumor cell clusters of ascites cell block in ovarian high‐grade serous carcinoma
por: Iwahashi, Hideki, et al.
Publicado: (2022)

Amino Acid-Metabolizing Enzymes in Advanced High-Grade Serous Ovarian Cancer Patients: Value of Ascites as Biomarker Source and Role for IL4I1 and IDO1
por: Grobben, Yvonne, et al.
Publicado: (2023)

Usefulness of vancomycin serum concentration monitoring in the critically ill patient
por: Bertolissi, M, et al.
Publicado: (2000)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lrgj8u48dcphgtdplbib5loqu1